NCT05544968
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05544968
Title Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Medical College of Wisconsin
Indications
Therapies
Age Groups: adult | child
Covered Countries USA


No variant requirements are available.